date:Jun 14, 2013
s of $13.3 million, which included $11.1 million income tax expense from valuation allowance for deferred tax assets, or $(0.23) per diluted share, in the previous quarter.
Full Year Ended March 31, 2013 Financial Results
Net sales for the full year of fiscal 2013 ended March 31, 2013 decreased to $265.8 million from $342.5 million in the prior year period. Net sales from branded powdered formula products decreased to $224.4 million, or 84% of net sales, compared to $301.7 million, or 88% of n